Jeffrey Chiang

Title: Innovations in Retinal Disease Detection by Jeffrey Chiang

Introduction

Jeffrey Chiang is an innovative inventor based in Los Angeles, CA. He has made significant contributions to the field of medical imaging, particularly in the detection of retinal diseases. His work focuses on utilizing advanced deep learning techniques to enhance the accuracy of biomarker predictions in optical coherence tomography (OCT) images.

Latest Patents

Jeffrey Chiang holds a patent for a groundbreaking method titled "Retinal disease biomarker prediction by stacking slices of 3D OCT image to reshape into 2D image and applying trained feature extractor and CNN." This patent describes systems and methods for detecting biomarkers within OCT volumes using deep learning approaches. The invention addresses the challenge of limited training data by leveraging a large external dataset of foveal scans through transfer learning. The method effectively represents the three-dimensional OCT volume by 'tiling' each slice into a single two-dimensional image, enhancing the network's ability to consider local spatial structures. The systems developed can identify the presence or absence of age-related macular degeneration (AMD)-related biomarkers with accuracy comparable to that of clinicians. Furthermore, additional models can be trained to predict the progression of these biomarkers over time.

Career Highlights

Throughout his career, Jeffrey has worked with prestigious institutions, including the University of California and the Doheny Eye Institute. His experience in these organizations has allowed him to refine his skills and contribute to significant advancements in retinal disease research.

Collaborations

Jeffrey has collaborated with notable professionals in his field, including Eran Halperin and Nadav Rakocz. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Jeffrey Chiang's contributions to the field of retinal disease detection through his innovative patent demonstrate the potential of deep learning in medical imaging. His work not only enhances the accuracy of biomarker detection but also paves the way for future advancements in predicting disease progression.